open access

Vol 10, No 5 (2014)
Case report
Published online: 2014-11-18
Get Citation

Some aspects of supportive care and diagnosis in the course of fulwestrant hormonotherapy of disseminated breast cancer

Piotr Plecka
Onkol. Prak. Klin 2014;10(5):258-262.

open access

Vol 10, No 5 (2014)
CASE REPORTS
Published online: 2014-11-18

Abstract

Breast cancer is the most common women neoplasm. Despite standard primary treatment, there are quite a lot cases who progress. So appropriate anticancer systemic therapy is necessary. Nowadays there can be used chemotherapy, hormonotherapy and immunotherapy. A case report of a female patient is presented, who progressed after six years of primary treatment. In spite of missing data of the estrogen and progesterone receptors status in the primary tumor, second and third line of hormonotherapy was introduced. Additionally local radiotherapy, oral and intravenous bisphosphonates, and strontium treatment were applied. 21 years of overall survival was accomplished and now during Fulvestrant treatment the patient is in remission. This case is the example of high efficacy of several lines of hormonotherapy in a estrogen-sensitive patient without need for chemotherapy.

Abstract

Breast cancer is the most common women neoplasm. Despite standard primary treatment, there are quite a lot cases who progress. So appropriate anticancer systemic therapy is necessary. Nowadays there can be used chemotherapy, hormonotherapy and immunotherapy. A case report of a female patient is presented, who progressed after six years of primary treatment. In spite of missing data of the estrogen and progesterone receptors status in the primary tumor, second and third line of hormonotherapy was introduced. Additionally local radiotherapy, oral and intravenous bisphosphonates, and strontium treatment were applied. 21 years of overall survival was accomplished and now during Fulvestrant treatment the patient is in remission. This case is the example of high efficacy of several lines of hormonotherapy in a estrogen-sensitive patient without need for chemotherapy.
Get Citation

Keywords

fulvestrant, breast cancer, supportive care

About this article
Title

Some aspects of supportive care and diagnosis in the course of fulwestrant hormonotherapy of disseminated breast cancer

Journal

Oncology in Clinical Practice

Issue

Vol 10, No 5 (2014)

Article type

Case report

Pages

258-262

Published online

2014-11-18

Bibliographic record

Onkol. Prak. Klin 2014;10(5):258-262.

Keywords

fulvestrant
breast cancer
supportive care

Authors

Piotr Plecka

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl